Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| cardiac muscle cell | 5 studies | 39% ± 9% |
Insufficient scRNA-seq data for expression of CORIN at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 97% | 544.54 | 238 / 245 | 56% | 2.06 | 281 / 502 |
| lung | 82% | 191.40 | 475 / 578 | 34% | 0.78 | 392 / 1155 |
| breast | 49% | 131.02 | 225 / 459 | 62% | 2.40 | 694 / 1118 |
| uterus | 90% | 758.14 | 153 / 170 | 12% | 0.31 | 56 / 459 |
| heart | 99% | 4714.34 | 849 / 861 | 0% | 0 | 0 / 0 |
| skin | 94% | 767.31 | 1700 / 1809 | 4% | 0.08 | 19 / 472 |
| esophagus | 67% | 126.49 | 962 / 1445 | 25% | 0.53 | 45 / 183 |
| stomach | 53% | 80.85 | 189 / 359 | 34% | 0.87 | 96 / 286 |
| spleen | 82% | 283.39 | 198 / 241 | 0% | 0 | 0 / 0 |
| bladder | 62% | 316.67 | 13 / 21 | 19% | 0.49 | 97 / 504 |
| pancreas | 12% | 13.60 | 39 / 328 | 69% | 2.59 | 123 / 178 |
| blood vessel | 77% | 153.90 | 1033 / 1335 | 0% | 0 | 0 / 0 |
| intestine | 43% | 60.17 | 416 / 966 | 29% | 0.80 | 155 / 527 |
| kidney | 46% | 106.12 | 41 / 89 | 7% | 0.17 | 59 / 901 |
| ovary | 33% | 113.05 | 59 / 180 | 16% | 0.32 | 67 / 430 |
| adipose | 24% | 52.23 | 289 / 1204 | 0% | 0 | 0 / 0 |
| thymus | 16% | 15.86 | 103 / 653 | 8% | 0.28 | 46 / 605 |
| adrenal gland | 9% | 9.15 | 22 / 258 | 15% | 0.58 | 34 / 230 |
| brain | 11% | 11.99 | 289 / 2642 | 1% | 0.01 | 5 / 705 |
| peripheral blood | 10% | 16.12 | 97 / 929 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 9% | 0.17 | 4 / 45 |
| liver | 1% | 1.09 | 2 / 226 | 7% | 0.27 | 27 / 406 |
| muscle | 3% | 5.60 | 25 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0003050 | Biological process | regulation of systemic arterial blood pressure by atrial natriuretic peptide |
| GO_0016486 | Biological process | peptide hormone processing |
| GO_0008217 | Biological process | regulation of blood pressure |
| GO_1903779 | Biological process | regulation of cardiac conduction |
| GO_0007565 | Biological process | female pregnancy |
| GO_0035813 | Biological process | regulation of renal sodium excretion |
| GO_0009986 | Cellular component | cell surface |
| GO_0015629 | Cellular component | actin cytoskeleton |
| GO_0016604 | Cellular component | nuclear body |
| GO_0005576 | Cellular component | extracellular region |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0004175 | Molecular function | endopeptidase activity |
| GO_0004252 | Molecular function | serine-type endopeptidase activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | CORIN |
| Protein name | Atrial natriuretic peptide-converting enzyme (EC 3.4.21.-) (Corin) (Heart-specific serine proteinase ATC2) (Pro-ANP-converting enzyme) (Transmembrane protease serine 10) [Cleaved into: Atrial natriuretic peptide-converting enzyme, N-terminal propeptide; Atrial natriuretic peptide-converting enzyme, activated protease fragment; Atrial natriuretic peptide-converting enzyme, 180 kDa soluble fragment; Atrial natriuretic peptide-converting enzyme, 160 kDa soluble fragment; Atrial natriuretic peptide-converting enzyme, 100 kDa soluble fragment] Corin, serine peptidase |
| Synonyms | TMPRSS10 CRN |
| Description | FUNCTION: Serine-type endopeptidase involved in atrial natriuretic peptide (NPPA) and brain natriuretic peptide (NPPB) processing . Converts through proteolytic cleavage the non-functional propeptides NPPA and NPPB into their active hormones, ANP and BNP(1-32) respectively, thereby regulating blood pressure in the heart and promoting natriuresis, diuresis and vasodilation . Proteolytic cleavage of pro-NPPA also plays a role in female pregnancy by promoting trophoblast invasion and spiral artery remodeling in uterus . Also acts as a regulator of sodium reabsorption in kidney (By similarity). .; FUNCTION: [Isoform 2]: Has weaker endopeptidase activity compared to isoform 1. |
| Accessions | J3KR88 ENST00000502252.5 E7EQE7 ENST00000508498.5 ENST00000273857.9 [Q9Y5Q5-1] J3KR83 ENST00000610355.4 Q9Y5Q5 ENST00000505909.5 ENST00000504584.1 J3KR90 A0A087X1D5 |